316 related articles for article (PubMed ID: 15871884)
1. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.
Al-Tureihi FI; Hassoun A; Wolf-Klein G; Isenberg H
J Am Med Dir Assoc; 2005; 6(2):105-8. PubMed ID: 15871884
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
Baxter R; Ray GT; Fireman BH
Infect Control Hosp Epidemiol; 2008 Jan; 29(1):44-50. PubMed ID: 18171186
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
Kaneria MV; Paul S
J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
[TBL] [Abstract][Full Text] [Related]
5. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Kim JW; Lee KL; Jeong JB; Kim BG; Shin S; Kim JS; Jung HC; Song IS
World J Gastroenterol; 2010 Jul; 16(28):3573-7. PubMed ID: 20653067
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
9. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
12. Burden of Clostridium difficile-associated diarrhea in a long-term care facility.
Laffan AM; Bellantoni MF; Greenough WB; Zenilman JM
J Am Geriatr Soc; 2006 Jul; 54(7):1068-73. PubMed ID: 16866677
[TBL] [Abstract][Full Text] [Related]
13. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
DuPont HL; Garey K; Caeiro JP; Jiang ZD
Curr Opin Infect Dis; 2008 Oct; 21(5):500-7. PubMed ID: 18725800
[TBL] [Abstract][Full Text] [Related]
14. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011.
Magee G; Strauss ME; Thomas SM; Brown H; Baumer D; Broderick KC
Am J Infect Control; 2015 Nov; 43(11):1148-53. PubMed ID: 26521932
[TBL] [Abstract][Full Text] [Related]
15. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for recurrence of clostridium difficile-associated diarrhoea.
Samie AA; Traub M; Bachmann K; Kopischke K; Theilmann L
Hepatogastroenterology; 2013 Sep; 60(126):1351-4. PubMed ID: 23262313
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
[TBL] [Abstract][Full Text] [Related]
18. Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea.
Campbell R; Dean B; Nathanson B; Haidar T; Strauss M; Thomas S
J Med Econ; 2013; 16(3):440-8. PubMed ID: 23356421
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors of Clostridium difficile-associated diarrhea in children].
Guo S; Xu XW; Dong F
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1836-40. PubMed ID: 22944235
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhoea in hospitalised patients.
Al-Eidan FA; McElnay JC; Scott MG; Kearney MP
J Clin Pharm Ther; 2000 Apr; 25(2):101-9. PubMed ID: 10849187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
